Merger creates $600-million-revenue data infrastructure company Fivetran CEO Fraser to lead combined company Deal highlights AI-driven data infrastructure demand Oct 13 (Reuters) - Data startups ...

Marketing used to rely a lot more on gut feeling. Creative directors would dream up campaigns over long lunches, and my team and I would blast messages to anyone who'd listen. We called it ...

Fivetran Inc. and dbt Labs Inc., two venture-backed developers of data management software, today announced plans to merge. The all-stock transaction is expected to create a company with nearly $600 ...

If Your Data Was Compromised in the 2024 Breach Those impacted by the 2024 breach, known as the AT&T 2 Settlement Class, can submit a claim for one of two payouts. If you lost money due to the hack on ...

This is read by an automated voice. Please report any issues or inconsistencies here. Gov. Gavin Newsom vetoed a bill that would have tracked data centers’ growing water footprint in California. He ...

Data startups Fivetran and dbt Labs will merge in an all-stock deal, creating a combined data infrastructure company with nearly $600 million in annual revenue, the two companies told Reuters. The ...

Data startups Fivetran and dbt Labs will merge in an all-stock deal, creating a combined data infrastructure company with nearly US$600 million ($920 million) in annual revenue, the two companies told ...

The UNC School of Data Science and Society and the School of Information and Library Science will be consolidating into a new school focused on artificial intelligence. According to a Q and A webpage ...

The deal unites two of the most recognisable names in the analytics and AI infrastructure world. George Fraser, CEO of Fivetran (pictured), will lead the combined company, while dbt Labs founder and ...

Victoria Police is set to become more data-driven in the way frontline police are equipped, with real-time information and mobility investments to be prioritised. Faced with escalating crime rates and ...

AUSTIN, Texas, Oct. 14, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...